News

News Archive

The Current issue of “The view from here” discusses various aspects of medicinal chemistry. The Current issue of “The view from here” discusses various aspects of medicinal chemistry.

July’s issue of “The View from Here” deals with the massive topic of Medicinal Chemistry.

Royal Society of Medicine appoints new President Royal Society of Medicine appoints new President

Mr Babulal Sethia will today be inaugurated as President of the Royal Society of Medicine. A consultant congenital heart surgeon at the Royal Brompton Hospital, Mr Sethia will take over from Professor Sir Michael Rawlins. Mr Sethia has published widely on aspects of congenital heart disease in children and adults. For the past 15 years he has been active in helping to develop cardiac services on an humanitarian basis in Africa, Asia, the Middle East and South America.

Work in science week sees National Geographic zoologist share her story to inspire next wave of future scientists Work in science week sees National Geographic zoologist share her story to inspire next wave of future scientists

This year the TV presenter and National Geographic explorer Lucy Cooke met with school students to give an insight into the different directions a career in science can take. The talk to students forms part of the UCB’s annual Work in Science week, which take place each year at the company’s UK R&D headquarters in Slough.

£4m dedicated to advancing the development and application of non-animal technologies, such as bioprinting human tissue £4m dedicated to advancing the development and application of non-animal technologies, such as bioprinting human tissue

Fifteen business collaborations, carrying out early-stage investigations into the feasibility of novel non-animal technologies, have received support from five key funding bodies, including the NC3Rs

Domainex Reports Success of its Lead Compound in Pre-clinical Model of COPD and Secures £1.4m Biomedical Catalyst Award

Domainex Ltd, a UK-based drug discovery company developing first-in-class small-molecule inhibitors of two closely-related pro-inflammatory kinases - TBK1 and IKK-epsilon (IKK?)-, today announced that its lead compound has demonstrated a more potent effect in a key model of chronic obstructive pulmonary disease (COPD) than either roflumulast or a p38 inhibitor. It has also successfully won a £1.4m Biomedical Catalyst Award to support further development towards Phase I clinical studies.

Blocking Memories Could Help Treat Drug Addiction Blocking Memories Could Help Treat Drug Addiction

In substance addiction, drug-associated memories are known powerfully to compel craving and drug seeking behaviour. Research by Professor Barry Everitt at the University of Cambridge, UK, indicates that disrupting the brain's memory pathways might point towards future addiction therapy approaches.